Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by ronrydellon Jul 29, 2013 1:54pm
298 Views
Post# 21636963

RE:RE:RE:RE:RE:RE:RE:Over and done

RE:RE:RE:RE:RE:RE:RE:Over and doneProbably fair to say that we're now in "gamble number two". The first one was in May-June as we all waited with bated breath as to the results of ASSURE. The non believers who sold prior to the halt did either very well or broke even depending on the basis. The others, like me, well.....now for stage two. The non believers will sell out completely, may have already done so or may as we continue the two cent or so slide. The others will hold out Hoping for a great report and hope for a $3-$5 sell out or big licensing agreement. The choice is for everyone now to make.

I do find it instructive to read all the past posts on the JDStox board (which is independent of this forum.) He speculatated, in a well taken post of May that even if the results would were stellar it would not necessarily reflect a large jump in market cap or share price.

For those who have never sold and are just in a state or perpetual wait..August may be a nail biter!
Bullboard Posts